Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

private payer

Bill Bonello Sees Opportunities In Diagnostic Services Companies

CEO SUMMARY: With the clinical laboratory industry now enjoying growing interest by professional investors, THE DARK REPORT traveled to New York City to meet with financial analyst William B. Bonello, of U S Bancorp Piper Jaffray. Bonello co-authored a just-released overview of what he ca…

Read More



Profitable Prices for New Lab Information Services

ONE RESPONSE TO THE CONTINUED CUTBACKS for laboratory test reimbursement during the 1990s was a deluge of papers and speeches by pathologists and lab executives hammering at the theme that laboratory information possesses the potential to improve the quality of healthcare outcomes while reducing the…

Read More



Accurate Costing of New Pap Technology Proves Interesting

CEO SUMMARY: Various new technologies intended to supplant conventional Pap smear screening must deliver improved clinical performance in a cost-effective manner. Joseph Plandowski, our guest writer,concludes his three-part series on new Pap smear technologies by evaluating actual lab cos…

Read More



Humana Denies Payment For Pathology CPT Codes

CEO SUMMARY: It’s not just the Medicare program that wants to eat away at the reimbursement for laboratory tests. Private payers continue to seek ways to cut back reimbursement to laboratory providers. The latest attack is on two surgical pathology codes—88300 and 88302. In at least t…

Read More



Pap Technology Wars Expected to Intensify

CEO SUMMARY: With patience and persistence, Digene, Inc. is developing the effectiveness of its DNA-based HPV assay. Publication of recently-completed clinical trials provides evidence that Digene’s Hybrid Capture II ® HPV test, with further improvement, might become a relevant tool in…

Read More



Clinical Lab and Pathology Informatics Merging For Internet Solutions

CEO SUMMARY: Information is where both clinical laboratories and anatomic pathologists will continue to add value to healthcare in the future. At this year’s Executive War College in May, THE DARK REPORT asked several leading innovators in laboratory and pathology informatics to share t…

Read More



Automated Pap Smear Screening Expected to Build Market Share

EXPECT 1999 TO BE A PIVOTAL YEAR in automated Pap smear screening. This new technology is now poised to enter general clinical usage. As it does, an increasing volume of clinical data will make the case: either automated screening of Pap smears is clinically effective and economically justified—or…

Read More



Pathology PPMs Unlike Most Other PPM Firms

PHYSICIAN PRACTICE MANAGEMENT (PPM) companies have arrived at pathology’s doorstep. For better or worse, a new era is pushing its way into the pathology profession. In the first installment of this exclusive DARK REPORT series, we exposed the rotten secret behind the …

Read More



“State of Lab Industry” Reveals Radical Change

CEO SUMMARY: Pick your trend: declining reimbursement, consolidation, clinical integration, downsizing, and capitated reimbursement. These trends all continued to shape the way laboratories organized to provide services. But 1997’s wildcard was the federal government. Between investigat…

Read More



Quest Diagnostics & SmithKline Release Third Quarter Financials

It appears that 1997 will be kinder to Quest Diagnostics Inc. and SmithKline Beecham Clinical Laboratories (SBCL) than the last three years. Both companies reported improved financial results for third quarter and mixed results for year-to-date. As of press time, …

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;